Trustworthy, Rapid Remediation to Address FDA 483 Warnings Case study on Trustworthy, Rapid Remediation to Address FDA 483 Warnings. Diane Gleinser - April 18, 2022 Case Studies Biotech Regulatory
Is There a Checklist for GCP Audits? Blog article topic: Is There a Checklist for GCP Audits? Bob Lucchesi - April 14, 2022 Blogs Biotech, CMO, CRO, Medical Device, Pharma Regulatory, Safety
How Do Life Science Companies Qualify Vendors and Software? Automated equipment & systems used by companies are supplied by vendors & are purchased off-the-shelf (OTS). They should audit the vendors development. David Blewitt - April 14, 2022 Blogs Biotech, CMO, CRO, Medical Device, Pharma Quality Assurance, Safety
Five Tips for Successful Veeva Implementation Blog article topic: Five Tips for Successful Veeva Implementation. Donald Zinn - April 14, 2022 Blogs Biotech, CMO, CRO, Medical Device, Pharma Information Technology
FDA CBD Enforcement Report Released to Congress Blog article topic: FDA CBD Enforcement Report Released to Congress. Joseph Cassella - April 14, 2022 Blogs Biotech, CMO, CRO, Medical Device, Pharma Regulatory
Work Faster and Smarter in Biotech Quality Management Discover how Box, ComplianceQuest, and USDM simplify quality management with bundled solutions. Save time, reduce costs, and streamline workflows. Webinars Biotech Information Technology, Quality Assurance
